|Mr. Christian Gormsen||CEO, Pres & Director||648.3k||N/A||1976|
|Mr. Adam Laponis||Chief Financial Officer||418.7k||358.8k||1976|
|Mr. William H. Brownie||Chief Operating Officer||428.45k||434.66k||1967|
|Mr. Daniel Shen||Co-Founder and Chief Clinical & Science Officer||N/A||N/A||N/A|
|Mr. Mark Thorpe||Chief Accounting Officer||N/A||N/A||1968|
|Mr. Tim Trine Ph.D.||Chief Technology Officer||N/A||N/A||N/A|
|Mr. Nicholas S. Laudico||Sr. VP of Corp. Strategy & Investor Relations||N/A||N/A||N/A|
|Ms. Christy La Pierre||Chief Legal Officer & Sec.||N/A||N/A||N/A|
|Mr. Frederick D. Knight CCEP, M.B.A.||Chief Compliance Officer||N/A||N/A||N/A|
|Mr. Pio Schunker||Chief Marketing Officer||N/A||N/A||N/A|
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Eargo, Inc.’s ISS governance QualityScore as of 1 January 2023 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 8; Compensation: 9.